This report details the precise mapping of a partially deleted human antithrombin 111 (AT-Ill) allele, found in a kindred with an inherited type 1 AT-Ill deficiency. Using truncated AT-Ill probes generated by polymerase chain reaction (PCR) amplification from a full-length AT-Ill cDNA, as well as other genomic probes specific for the 5' upstream region of the AT-Ill gene, we were able to characterize a partial deletion on an AT-Ill allele encompassing exons 1 and 2 of the AT-Ill gene, and a region 5' to the coding sequences. The absence of the 5' upstream region in the affected AT-Ill allele was confirmed directly by the PCR amplification of a 1.5-kb polymorphic fragment of genomic DNA samples from family members. The precise determination of the 5' breakpoint of the affected allele was made possible by two different approaches: (1) NTITHROMBIN I11 (AT-111) is the major plasma A glycoprotein inhibitor of blood coagulation. It inhibits the activated serine esterases of the coagulation pathway, principally thrombin.' Inherited AT-I11 deficiency comprises a heterogenous group of disorders in which a gene, or gene product, is either missing (type 1); or in which the expression from one AT-I11 allele results in an abnormal protein lacking thrombin or heparin affinity, coinciding with point mutations in the thrombin (type 2) or heparin (type 3) binding domains of AT-III.2-6 In most patients with type 1 AT-I11 deficiency, several investigators have shown that both AT-I11 alleles are grossly intact with the mutant alleles containing small insertions, deletions, or singlepoint mutation^.^-^ The total absence of one AT-I11 allele has been reported only in one kindred.2 In this article, we present evidence for an extensive partial deletion of one AT-I11 allele in a kindred phenotypically presenting with a type 1 AT-I11 deficiency.
The oligonucleotides used for polymerase chain reaction (PCR) amplification were synthesized by the Institute for Molecular Biology and Biotechnology, McMaster University (Hamilton, Ontario, Canada). 5' amino modification and biotinylation of the primer used for cloning of the 5' breakpoint of the deletion was performed by VetroGen Corp (London, Ontario, Canada). All other chemicals and reagents used were the highest grade available.
Southem Blot Analysis of the AT-ZZZ Gene in the Affected Kindred
Genomic DNA was isolated from circulating peripheral blood leukocytes by the method of Poncz et a1.7 Samples of genomic DNA (10 kg) were digested with a battery of restriction enzymes and subjected to electrophoresis in 0.8% agarose gels. DNA was transferred to quaternary amine-derivatized nylon membranes according to the manufacturer's instructions. Prehybridization and hybridization (performed at 42°C) were performed in 50% formamide (pH 7.2) containing 0.25 mol/L dibasic sodium phosphate 7-hydrate (NaZHP04 .7H20), 0.25 mol/L sodium chloride (NaCl), 7% sodium dodecyl sulfate (SDS), 1 mmol1L ethylenediaminetetracetic acid (EDTA), and 100 pg/mL of denatured salmon sperm DNA. Washing was performed twice at room temperature in sodium chloride citrate (SCC) buffer (pH 7.0) containing 0.15 mol/L NaC1, 0.015 mol/L trisodium citrate (10 minutes for each wash); and twice at 51°C in 0 . 1~ SCC also containing 0.1% SDS (30 minutes for each wash). The blotted DNA samples were reprobed after washing twice for 15 minutes at 95°C in 0.1 x SCC containing 0.1% SDS. This procedure was controlled by overnight exposure at -70°C in the presence of two intensifying screens.
Three types of probes were used for the hybridizations as follows.
(1) A full-length 1.5-kb human AT-111 cDNA fragment (provided by Dr E.V. Prochownik, University of Michigan, Ann Arbor, MI) was used containing 8 nucleotides of 5' untranslated region, all the sequences for the 32 amino acids of the presequence and the 432 amino acids of mature AT-111, and 87 nucleotides of the 3' untranslated region. (2) Also used were truncated probes generated from the full-length AT-I11 cDNA by PCR amplification. The
CA-3';3'toexon3,5'-TTGAAGTCCAGGGGCTGGAG-3';5'
to exon 3,5'-GTA TlT AAG TTT GAC ACC ATA TCT G-3'; 5' to exon 5,5'-GGC CTG TGG AAG TCA AAG TT-3'; 5' to exon 6, 5'-GTA TTG CAG AAG GCC GA-3'; and 3' to exon 7, 5'-CTT CTG 7TC ACA AAC CAA AAA T-3'. PCR amplification used 10 pmol of each primer in a buffer containing 10 mmol/L Tris-HC1, pH 8.3, 2.5 mmol/L MgC12, 50 mmol/L KCl, 200 pmol/L each dNTP, and 0.01% gelatin. After5 minutes of precycle incubation at 95°C for DNA denaturation, the samples were cooled to 72"C, the temperature at which 2.5 U of Taq polymerase was added, and each tube was overlaid with mineral oil. Thirty cycles of amplification were performed with denaturation for 2 minutes at 93"C, annealing as detailed further below, and extension for 2 minutes at 72°C. The last extension cycle was for 15 minutes. Annealing for cDNA exons 1 and 2 (0.40 kb) was for 1.5 minutes at 50°C; for exons 1 through 3 (0.62 kb) for 2 minutes at 50°C; for exons 3 through 7 (1.03 kb) for 2 minutes at 60°C; for exons 5 through 7 (0.68 kb) for 2 minutes at 55°C; and for exons 6 and 7 (0.23 kb) for 1 minutes at 55°C. ( 3) The genomic DNA probes used were as follows. A Pst I 1.2-kb fragment encompassing the 5' untranslated region, as well as exon 1, and part of the first intervening sequence (IVS 1) provided by Dr S. Bock (Temple University, Philadelphia, PA) was used. Similar probes containing either the 1.2-kb or the 1.7-kb Pst I fragments were generated in our laboratory after partial Sau3A digestion of normal genomic DNA and ligation to EMBL 3 BamHI phage arms. BamHI 1.4-kb or 1.5-kb inserts, encompassing exon 1 and the 5' upstream sequence of the AT-I11 gene, were obtained from the same phage libraries. All subcloned probes were digested and purified by polyacrylamide gel electrophoresis (PAGE). PCR probes were also PAGE-purified to remove unincorporated nucleotides. Each probe was then labeled by the random primer extention method8 using CX[~~P]-~ATP, and purified by Sephadex G50 chromatography. Specific activities ranged from 0.5 to 2.0 x lo7 cpm/ng and lo6 cpm/mL was used for each hybridization.
PCR Amplification of the 5' Region Upstream to the Gene
To confirm the restriction fragment length polymorphism (RFLP) analysis indicating the absence of the 5'-region immediately upstream to the affected AT-111 allele, PCR amplification of a BumHI to BumHI 1.5-kb fragment spanning a region of the gene 1.1 kp upstream to exon 1, exon 1, and 0.3 kb of IVS-1 was performed using genomic DNA samples from each family member. The oligonucleotides used were 5'-TCG GAT CCA GGG TCT GAA TCA AC-3' (the 5' primer) and 5'-GGA TCC CGT GAG TGC TGA CIT-3' (the 3' primer). These were selected according to previously published sequences of normal human AT-111 alleles (the 3' rimer)^ and after sequencing the wild-type allele (the 5' primer). Sequencing of the BamHI fragments of normal DNA genomic clones was performed by subcloning into the BumHI site of pGEM 3ZF+ and using T7 DNA polymerase together with the dideoxy chain termination method according to the manufacturer's instructions. The buffer system used for PCR amplification was as described previously.'0 After a precycle with 5 minutes of denaturation at 95T, the samples were cooled to 72"C, 2.5 U of Taq polymerase was added, and each tube overlaid with mineral oil. Then 30 PCR cycles were performed, each with 2 minutes of denaturation at 92"C, 2 minutes of annealirig at 56T, and 2.5 minutes of extension at 72°C with autoextension for 5 seconds. The resulting products were analyzed on 2% agarose and purified by PAGE before restriction analysis.
Determination of the 5' Breakpoint of the Mutant AT-111 Allele
Genomic DNA (300 pg) from the mother of the proposita was digested to completion with Pst I, using six successive digestions with 100 U of Pst I (50 U/mL), separated by DNA reextraction. This was followed by DNA-sizing on sucrose density gradient. Fractions containing 9 to 11 kb and 4 to 6 kb, respectively, were pooled and then purified by dialysis and ethanol precipitation." The presence of AT-I11 gene-related material in the sized material selected was confirmed by Southern analysis with a probe encoding AT-111 cDNA (4 pg of DNA was used). Two approaches were then used to clone the region of the breakpoint.
( I ) Subcloning and biotin capture PCR. One microgram each of the Pst I 9-to 11-kb and 4-to 6-kb fractions was subcloned into pGEM 3ZF+ at a 3:l insert to vector molar ratio using T4 DNA ligase (4 U) for 12 hours at 16°C in a final volume of 10 pL in buffer containing 50 mmol/L Tris-HC1 (pH 7.8), 10 mmol/L MgC12, 20 mmol/L DTT, 1 mmol/L ATP, and 50 pg/mL bovine serum albumin. Then, 1/10 of the ligation mix was PCR-amplified in a 100 pL reaction volume (using the same buffer conditions as described above) using 50 pmol of only one primer, biotinylated at its 5' end and complementary to the 3' boundary of exon 3 ( 5 ' -C l T GAA GTC CAG GGG CTG GAG C-3'). After denaturation and enzyme addition, 35 cycles of amplification were performed with denaturation at 92°C for 2 minutes, annealing at 53°C for 2 minutes, and extension at 72°C for 3 minutes (plus 1 second of autoextension per cycle). Isolation of the biotinylated PCRamplified product was accomplished using streptavidin beads as described by Rosenthal and Jones.12 This step was followed by a second round of PCR amplification for 30 cycles using 20% of the isolated PCR product bound to the magnetic beads, with 2 minutes of denaturation at 92"C, 2 minutes of annealing at 48"C, and 3 minutes of extension at 72°C. The 5' primer used was part of the SP6 promoter regiod (5'-GAT l T A GGT GAC ACT ATA-3') located in the cloning vector 21 bases upstream to the Pst I subcloning site. The 3' primer used was an oligonucleotide complementary to the 5' boundary of exon 3 (5'-CTC CAT ATA CCA ACT CAC TG-3'), a location nested to the biotinylated amplimer. The PCR products obtained were analyzed on agarose gels and their AT-I11 specificity confirmed by Southern analysis using truncated AT-I11 cDNA.
One microgram of 9-to 11-kb sized Pst I genomic DNA fractions was circularized in a 25 ILL reaction volume, using 4 U of T4 DNA ligase for 20 hours at 16"C.13 PCR amplification was performed in two steps, the first using the biotinylated primer complementary to exon 3 (see PCR amplification conditions above) and the second using two primers for a second round of amplification (30 cycles) on 20% of the bound biotinylated product, with 2 minutes of denaturation at 92"C, 2 minutes of annealing at 53T, and 3 minutes of extension at 72°C.
The 5' primer selected was located at the end of IVS 6, 93 bases upstream to the Pst I site, directly flanking exon 7 (therefore at the 3' end of the sized Pst I fractions containing the mutant allele) (5'-TGA GGA ATT GCT GTG TCT GTG-3'). The 3' primer was (as described above) the nested primer complementary to exon 3.
The PCR products obtained with either technique were PAGE purified and sequenced either directly or after subcloning into pGEM 3ZF+ or pGEM 7ZF+, using the dideoxy chain termination method. This was performed concommitantly with sequence determination of the normal allele of approximately 1,200 bases immediately 5' to exon 3. The nucleotide sequences were determined for the amplified product and for normal AT-111 genomic Hind111 toHindIII, 2.6-and 2.2-kb subcloned fragments, encompassing the region of interest between exons 2 and 4. 
RESULTS

Family History and Coagulation Assays
The genetic details of the kindred with type 1 AT-I11 deficiency that we investigated in this study are shown in Fig  1. AT-I11 antigenic and functional activities towards both factor Xa and thrombin were determined with citrated plasma samples using previously described methods.14J5 The proposita, her mother, and one sibling had reduced plasma AT-I11 activities (both immunologic and functional). No electrophoretically abnormal AT-I11 species were detected by immunoelectroblotting plasma samples from affected individuals with rabbit antihuman AT-I11 antiserum in 6% to 15% gradient gels (data not shown). All affected individuals had a history of recurrent thromboembolic episodes. The proposita, for example, has had both a pulmonary embolism and recurrent episodes of deep venous thrombosis during two pregnancies. In addition, a sibling of the proposita died of a pulmonary embolus after an appendectomy at age 17. The father of the proposita and two other siblings are normal. HindIII (Fig 4) , and HindIII + Pst I (Fig 5) . For each of these figures a normal restriction map is included (eg, see Fig 3D) to indicate the regions encompassed by the probes used for mapping. Restriction analyses with EcoRI, EcoRI + Pst I, HindIII, BamHI, BamHI + EcoRI, and Bgl I1 are not illustrated in this report, but were also performed. A summary of all the restriction mapping data is shown in Fig  6A .
Pst I restriction analysis (Fig 3) was performed using a full-length cDNA probe (probe a in Fig 3A and D) . As expected from the normal restriction map, fragments of 1.8 kb encompassing exon 2, of 10.5 (or 5.5 + 5.0) kb encompassing exons 3 to 6, and of 2.5 kb encompassing exon 7 could be detected. As shown in Fig 3A, the expected fragments were detected in all unaffected individuals (1,3, and 5), whereas in all affected individuals (2, 4, and 6), an abnormal 9.5-kb fragment was also seen. In addition, this RFLP analysis allowed the association of the normal AT-I11 allele of the mother (individual 2), who was affected, to a normal AT-I11 allele containing an intragenic Pst I polymorphic site in exon 5. This was shown by the presence of 5.5-and 5.0-kb fragments. This normal allele was also inherited by the two normal siblings of the proposita, individuals 3 and 5. For more detailed mapping of the AT-I11 genes, truncated probes (b, c, and d) generated by PCR amplification were tested (as shown for the mother in Fig 3B) . These probes did not provide any indication of other variations from the normal restriction pattern in the abnormal allele. The full-length cDNA probe (probe a) did not enable the study the S'-upstream region of the AT-I11 gene, even though it included exon 1. Therefore, genomic probes (e) were used to examine this region (Fig 3C) . This 5'-upstream region contains a polymorphism defined by the presence, or absence, of a 110-bp fragment shown in detail in the enlarged portion of Fig 2.9 The presence of this 110-bp fragment is indicated by the presence of a 1.2-kb Pst I fragment (the Pst I polymorphic site being situated within the 110-base fragment); its absence is indicated by a 1.7-kb Pst I fragment. As can be seen in Fig 3D, the results of the Southern blot analysis with Pst I for the father (individual 1) and the mother of the proposita (individual 2) showed a 1.7-and 1.2-kb fragment, respectively. The inheritance pattern for normal siblings 3 and 5 was the presence of 1.2-and 1.7-kb fragments. In contrast, the inheritance pattern for affected siblings 4 and 6 showed the presence of only one 1.7-kb fragment. If both alleles had been detected by a probe encompassing this region of the gene, a 1.2-kb fragment inherited from the mother should also have been seen. This analysis thus indicated the presence of only the fragment inherited from the paternal wild-type AT-I11 allele, and nothing from this portion of the maternal mutant AT-I11 allele. EcoRI restriction analysis (data not shown) did not detect any additional abnormal fragments in affected individuals, even when truncated probes were used. When 5' genomic probes were used, a reduction in the radioactive intensity of the 10.5-kb fragment encompassing exons 1 to 5 (as compared with normal individuals) was observed in For personal use only. on November 11, 2017. by guest www.bloodjournal.org From 
2), 2.2 kb (encompassing exons 3 and 4), and 6.8 kb (encompassing exons 5 to 7). This abnormal fragment hybridized less strongly than expected, even when varying washing conditions were used for the Southern analysis. This was accompanied by a reduction in the intensity of the 2.6-kb and 2.2-kb fragments in affected individuals, suggesting that these fragments were missing in the mutant AT-I11 allele. Use of 5' upstream genomic probes enabled the detection of a 6.0-kb Hind111 fragment that was reduced in intensity, in affected individuals, suggesting that this fragment was missing in the mutant allclc. This was confirmed when Hind111 plus EcoRI were used (see Fig 4) . When the whole gene was probed (probe a), an abnormal 5.2-kb fragment was detected in affected individuals (see individual 2 in Fig 4) . The normal restriction pattern, as indicated in the accompanying map and as illustrated for individual 1 (the father of the proposita), generated fragments of in the 5' region of the gene: a 4.2-kb fragment encompassing exon 1; a 2.6-kb fragment encompassing exon 2; a 2.2-kb fragment encompassing exons 3 and 4; a 1.3-kb fragment encompassing exon 5; and a 4.0-kb fragment encompassing exon 6. The use of truncated probes allowed us to show that the abnormal 5.2-kb fragment was only hybridizing to exons 3 to 4, and that it was due to a rearrangement of the Hind111 site normally present immediately 5' to exon 3. No other anomaly was noted in the region encompassed by exons 5 to 7, providing identical restriction patterns in both affected and nonaffcctcd individuals.
BumHI restriction analysis (data not shown) gave, in all affected individuals, an unexpected fragment of 9.5 kb, in addition to the presence of a normal 1.4-and/or 1.5-kb fragment encompassing exon 1; a 10.5-kb fragment encompassing exons 2 to 6; and a 5.0-kb fragment encompassing exon 7. Further mapping with truncated probes provided data to indicate that the unexpected 9.5-kb BumHI fragment did not hybridize with a probe that included exon 2, but hybridized with a probe that included exon 3. No other abnormalities were noted in the 3' end of the gene. The use of Sl-genomic probes alone allowed us to confirm the absence of exon 1, as seen with Psf I, in affected individuals.
EcoRI + BumHI restriction analysis (data not shown) gave, in affected individuals, an abnormal 5.6-kb fragment hybridizing only with probes encompassing exons 3 to 5, together with normal fragments of 1.4 and/or 1.5 kb (encompassing exon 1); 7.5 kb (encompassing exons 2 to 5); 2.6 kb (encompassing cxon 6); and 1.3 kb (encompassing exon 7).
Bgt 11 restriction analysis (data not shown) did not give any unexpected fragments when probes encompassing the whole gene were used. The only anomaly was a reduction of radioactivity in the affected individuals when 5' probes were used (and also when truncated probes encompassing exons 1 and 2 were used). The normal pattern, as indicated in Fig 6, gave a 10 .5-kb fragment encompassing exons 1 and 2 and an 8.5-kb fragment encompassing exons 3 to 6. When a probe encompassing exons 1 to 3 was used, the restriction pattern still appeared normal for both affected and unaffected individuals. Nevertheless, the use of truncated probes encompassing exons 3 to 7 enabled us to detect a mutant 10.5-kb fragment, in addition to the presence of an expected 8.5-kb fragment. This was due to a rearrangement of the twoBgl I1 sites normally situated between exons 2 and 3. This was initially difficult to detect, because the rearranged piece had the same size (10.5 kb) as that of the normal fragments seen in normal individuals, and was therefore masked when using only a full-length cDNA probe. No other abnormality was seen towards the 3' end of the gene with this restriction enzyme.
Because the above Southern analyses suggested the possibility of a gene inversion, restriction analysis with both Hind111 and Pst I digests (shown in Fig 5 ) was performed. The mother of the proposita (individual 2) was selected for investigation because shc was thc only affected individual availablc for whom it was possible to diffcrcntiatc wild-typc and mutant AT-Ill allclcs using thc prcscncc of the intragcnic Pst I polymorphic sitc in cxon 5. As expected, hcr normal AT-Ill allclc, linkcd to thc A t I intragenic polymorphism, gcneratcd a 5.5-kb Pst I fragment (cncompassing cxons 5 to 6) and a 0.85-kb Hindlll-Pst I fragment; whereas hcr abnormal allclc with no Psr I sitc in cxon 5 gencrated a 6.35-kb Hindlll-Pst I fragment. The prcscncc of 6.3-, 5 5 , and 0.85-kb fragmcnts in thc mothcr's samples indicated that thc 3' cnd of the mutant AT-I11 allcle was intact. Southern analysis using a truncatcd probe (Fig 5, probe c ) also showcd the prcsencc of an abnormal 3.0-kb PSI I-Hind111 fragment in the abnormal AT-Ill allele. As seen with probes cncompassing rcgions b and c in Fig 5, the Hind111 site that was normally located just 5' to exon 3 was missing, whereas the Hind111 site normally locatcd 3' to exon 4 was present. All these data arc summarized in Fig 6. The deleted part of the gene (indicated by the dashcd lines) is located upstream to cxon 3. The combincd data indicate the restriction map for the partially dclcted mutant AT-Ill allele shown in Fig 6B. Thc proposed rcarranged restriction sites for HindIII, BumHI, Egl 11, and Pst I arc shown at the 5' end of the affected allele. This map was used to select the restriction sites for determining the breakpoint in the mutant AT-I11 allele.
PCR Amplification of the 5' Region Upstwam to the AT-Ill
Gene
To confirm that sequences upstream of the transcriptional unit were missing in the mutant AT-I11 allele, and to avoid problems inhercnt in Southern analysis, the EumHI 1.55-kb and/or thc 1.45-kb fragment of the 5' region of the gene (see insert to Fig 2) wcre amplified dircctly using genomic DNA samplcs from various individuals of this kindrcd. PCR-amplified material from the mothcr of thc proposita (individual 2) gave a single band, a 1.55-kb product; and that from the father of thc proposita (individual I ) gavc a 1.45-kb product (Fig 7A) . As expected, an unaffcctcd sibling (individual 3) had both 1.55-and 1.45-kb fragmcnts. However, PCR amplification of this rcgion using DNA from the proposita gavc only a 1.45-kb fragment. Thcse rcsults clearly indicatcd that this rcgion of the affccted AT-Ill allclc was missing in genomic DNA from thc proposita and her mothcr. This was confirmed when PCR-amplified matcrial from thcse four individuals was purified by PAGE and then digested with Pst I (Fig 7B) . I . -... Fig 2) in an individual was associated with the presence of two fst I cleavage fragments of 0.75 and 0.62 kb, respectively. The absence of this f s t I length polymorphism resulted in the finding of only a 1.3-kb fragment. Furthermore, when the 1.55-and 1.45-kb pieces werc both PCR amplified, heteroduplexes were seen even after agarose gel elcctrophoresis only in the normal siblings (data not shown). They could be detected in agarose gels after 35 cyclcs of amplification (as an additional band migrating in the 3 kb area) and also after PAGE as additional slow moving bands above the normal bands. Thcsc data confirmed the presence of only one species of DNA fragment in affected individuals. Figure 8 shows the PCR-amplified products obtained in 1.8% agarose gels after subcloning, two-step PCR, or inverse PCR. Whcn sized fragmcnts from the mother of the proposita were subcloned (cithcr 9-kb fragments from the mutant AT 111 allele or 5-kb fragments from the wild-type AT-I11 allele), it was necessary to separate the AT-I11 alleles inserted into the fsr I site of the vector from unligated inserts and unligated vector. Therefore, the first round of PCR, using only the biotinylated primer complementary to exon 3, avoided unwanted annealing of the two primers used for the second round of PCR amplification to unligated material. Control PCR reactions with this primer alonc (or with the two primers used for the second round of PCR) in the ligation mix generated multiple bands, which hybridized to AT-Ill cDNA as a smear of radioactivity (data not shown). The second round of PCR using biotinbound product on the streptavidin beads allowcd us to obtain a single band of 2.9 kb (Fig 8, lane 3) for the 5-kb fraction and a single band of 1.4 kb (Fig 8, lane 1) for the 9.5-kb fraction. Both products were shown to be AT-111-specific and to contain exon 3 by Southern analysis (data not shown). Restriction mapping of these products, either directly on the PAGE-purified products or after subcloning into pGEM 7ZF+, confirmed the presence of normal restriction sites upstream to exon 3.16 A Hind111 digest of the normal PCR product is shown in Fig 8, lane 6 , which shows the presence of one Hind111 site approximately 700 bases upstream to the 5' boundary of exon 3. The same digest of the abnormal PCR product did not detect any Hind111 site, confirming the Southern analysis provided above. An inverse PCR approach was attempted to confirm the results for the abnormal PSI I-exon 3 breakpoint in the deleted allele, and because Southern analysis indicated that the mutant allele was normal in its 3' end. After circularization of the 9.5-kb fraction, linear PCR, and a second round of PCR, a product of the expected size was obtained. This product is shown in Fig 8, lanes 4 (undigested product) and 7 (Hind111 digest). Direct PCR amplification, without the linear PCR step, using the recircularized Psf 1 9-kb fractions generated the expectcd product, but at low yield, as well as additional bands (data not shown). Linearization of the circularized fractions'O was not necessary in this case and did not improve reaction specificity. Sequence determination was then performed for both the wild-type and mutant alleles and these results are shown in Figs 9 and 10. As shown in Fig 9,480 bases upstream to the 5' margin of exon 3, different sequences were obtained for the wild-type (lane A) and the mutant allele (lane B). Sequencing was performed in both directions for the wild-type alleles amplified and/or subcloned and for the mutant allele breakpoint for both approaches. Figure 10 details the normal and abnormal sequences obtained for approximately 1.2 kb upstream to the 5' boundary of exon 3. In the mutant AT-I11 allele, the breakpoint creates two new restriction sites for Suu961 (G GNCC) and Hue 111 (GG CC), respectively. Finally, PCR amplification in the region of the breakpoint (data not shown) provided a product of 620 bp in all affected individuals of this kindred. This product could not be detected in any unaffected members of this kindred or in any control subjects. reported thus far, the two AT-I11 alleles appear to be grossly intact:." with small insertions or deletions found within the coding sequences of the AT-I11 cDNA."*".'* Nevertheless, Southern analysis may still be informative and should be the first step in the investigation of this type of defect before embarking into PCR amplification and the sequencing of the various exons and splicc junctions of the AT-I11 gene. Linkage analysis is facilitated by a number of polymorphisms throughout the gene.s. 6 The present kindred with type 1 AT-I11 deficiency provides further information about the heterogeneous molecular nature of type l AT-I11 deficiency. Southern analysis showed that this type AT-I11 deficiency was associated with a deletion of exon 2, IVS-1, and IVS-2, as well as a region at least 8 kb 5' to the AT-I11 gene. Absence of exon 2 in the mutant allele was also deduced by Southern analyses. These results were confirmed by PCR amplification of the 5' region upstream to exon 1, exon 1, and part of IVS-1 of the mutant allele. The location and the sequence at the breakpoint of the deleted allele was confirmed by two approaches: subcloning the abnormal AT-I11 allele and amplification of AT-111-related sequences 1.2 kb upstream to the IVS-2-exon 3 boundary by PCR, and by inverse PCR. Finally, PCR amplification of the region of the breakpoint provided unique products seen only in affected members of this kindred.
Determination of the 5' Breakpint of the Deleted Allele
Computer analysis14 did not find any significant homology between the sequenced area of the mutant AT-I11 allele, upstream to the breakpoint, with any other reported human sequence. The 3' end of the mutant AT-I11 allele is clearly evident from the RFLPs obtained using double digestions such as with Hind111 and PSI I, and by the fact that inverse For personal use only. on November 11, 2017. by guest www.bloodjournal.org From
